HOME › Research Insight › Therapeutic Proteins, Contract Research Organizations, and Asian Countries Are the New Revenue Pockets in the Global Protein Expression Market
Therapeutic Proteins, Contract Research Organizations, and Asian Countries Are the New Revenue Pockets in the Global Protein Expression Market
Protein expression is the manufacture of a protein derived from recombinant DNA. Owing to the advancements in the proteomic industry, the demand for protein expression related activities has increased tremendously in the recent years. The increasing research intensity in the pharmaceutical sector has fuelled the growth of this market. As such, the protein expression industry remains a lucrative field to invest
The applications segment of the protein expression market comprised of industrial proteins, research, and therapeutic proteins. Of these, the therapeutic proteins segment commanded the largest share of the global protein expression market in 2013 and is also poised to grow at the highest CAGR between 2013 and 2018. Using proteins as therapeutic agents has gained momentum on account of several reasons Therapeutic proteins serve highly specific and complex set of functions that cannot be mimicked by simple chemical compounds. Further, biological products like therapeutic proteins have higher immuntolerance and are ideally suited therapeutic candidates. In addition, the biologics market is expected to reach $221 billion in 2017 from $169 billion in 2012. This surge in biologics will boost the demand of therapeutic proteins and thus bolster growth of the protein expression market.
The end-user segments included in this report are academic research, pharmaceutical and biotechnological companies, contract research organizations, and other end users. Of these, the contract research organizations segment is poised to grow at the highest CAGR between 2013 and 2018. With the advancements in proteomics and the rising costs, it has become more difficult for pharmaceutical and biotechnological companies to manage costs. In order to overcome the deficit, outsourcing most of the proteomics research work to contract research organizations is becoming more economical for such companies. In addition, many infant research labs and companies lack either the resources or expertise in protein expression. In such cases too, contract research organizations play an important role in providing resources and expertise in protein expression market.
Based on geography, the global protein expression market is segmented into Asia, Europe, North America, and Rest of the World (RoW). Of these, the Asian segment that includes the regional segments of China, India, Japan, and Rest of Asia (RoA) is expected to grow at the highest CAGR between 2013 and 2018. The growth in the Asian economies, particularly in China and India along with the increasing investments in biotechnology in Asia will be the major drivers for growth in the Asian protein expression market. In addition, the Asian region has witnessed an upward trend in the proteomics market over the past few years as many North American and European pharmaceutical drug manufacturers find it cost-effective to outsource their proteomics-based work to Asian manufacturers or set up their own manufacturing facilities in the Asian countries.
Thus, on account of the rise in demand of biologics, therapeutic proteins emerge as a lucrative revenue pocket. The demand for therapeutic proteins will handsomely reward investments made in the therapeutic protein industry. In the forecast period between 2013 and 2018, contract research organizations will provide generous returns on investments on account of the rising trend in outsourcing of research activities. Similarly, the economic developments in the Asian region will make the Asian countries one of the most lucrative revenue pockets in the global protein expression market. Investments made in the Asian proteomics industry will reap heavy dividends.
Protein Expression Market by Products (Expression Vector, Service, Reagent), Application (Industrial, Therapeutic), Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast) & by End User (Pharmaceutical, Biotechnology, CRO) - Global Forecast to 2018
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252